Parameters | B | SE | HR | Hazard ratio (95% CI) | P |
---|---|---|---|---|---|
Tumor volume (ypTV) | |||||
ypTV1 | – | – | – | – | – |
ypTV2 | 0.10 | 0.30 | 1.08 | 1.01–1.61 | 0.045 |
ypTV3 | 0.43 | 0.21 | 1.53 | 1.02–2.31 | 0.042 |
ypTV4a | 0.69 | 0.32 | 1.99 | 1.06–3.72 | 0.032 |
ypTV4b | 0.89 | 0.30 | 2.44 | 1.35–4.41 | 0.003 |
ypN stage | |||||
N0 | – | – | – | – | – |
N1 | 0.63 | 0.27 | 1.88 | 1.11–3.2 | 0.019 |
N2 | 0.65 | 0.22 | 1.92 | 1.25–2.93 | 0.003 |
N3 | 0.70 | 0.27 | 2.01 | 1.18–3.42 | 0.010 |
ypTvNM stage | |||||
I | 1.00 | ||||
II | 0.22 | 0.07 | 1.25 | 1.09–1.43 | 0.001 |
III | 0.64 | 0.23 | 1.90 | 1.22–2.96 | 0.005 |
Response to neoadjuvant chemotherapy | |||||
PR | – | – | – | – | – |
SD | 0.44 | 0.23 | 1.65 | 1.08–2.43 | 0.041 |
PD | 0.61 | 0.23 | 1.85 | 1.17–2.92 | 0.009 |
Vascular invasion | |||||
No | – | – | – | – | – |
Yes | 0.45 | 0.22 | 1.58 | 1.03–2.4 | 0.035 |